Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal
Crossref DOI link: https://doi.org/10.1007/s40273-018-0743-1
Published Online: 2018-11-22
Published Print: 2019-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Claxton, Lindsay http://orcid.org/0000-0002-1795-7568
O’Connor, Joanne
Woolacott, Nerys
Wright, Kath
Hodgson, Robert
Text and Data Mining valid from 2018-11-22
Article History
First Online: 22 November 2018